NCT01045343

Feasibility Study of an Integrated Diagnostic System to Manage Heart Failure

Integrated Diagnostics Can Alter Heart Failure

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 136 (actual)
• Sponsor: Medtronic Cardiac Rhythm and Heart Failure · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this clinical trial is to evaluate the potential benefits of a new heart failure diagnostic system for heart failure patients with implanted cardiac resynchronization therapy devices. This system consists of patient tools, a new heart failure risk score and a new clinician website. This study will evaluate this new system as a whole and establish the feasibility of implementing it into clinical practice.

Conditions

• Heart Failure

Interventions

Type	Name	Description
OTHER	Integrated diagnositic system	Heart failure will be managed using the integrated diagnostic system which consists of patient tools and a new Heart Failure Clinician's website which displays a new Heart Failure Risk score. This Heart Failure Clinician's website will be reviewed every 2 weeks in addition to scheduled in-office visits every three months.
OTHER	Routine in office visits	Heart failure will be managed with scheduled in-office visits every three months.

Timeline

• Start date: 2010-03-01
• Primary completion: 2012-02-01
• Completion: 2012-02-01
• First posted: 2010-01-11
• Last updated: 2012-04-17

Locations

13 sites across 1 country: United States